Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Reference Guide
  /  
AARS
Sign up free to test for 
AARS
.
One login for 30+ lab companies.

AARS

Alanyl-tRNA Synthetase (AARS) is a key player in the intricate process of protein synthesis within the cell. 

Specifically, AARS is an enzyme responsible for catalyzing the attachment of specific amino acids to their corresponding transfer RNA (tRNA) molecules during the process of protein synthesis, ensuring accurate translation of the genetic code into functional proteins.

Testing for the single nucleotide polymorphism (SNP) of AARS enzyme can identify genetic variations that may impact protein synthesis, potentially leading to insights into the pathogenesis of certain diseases or guiding personalized treatment strategies.

Emerging research points to AARS in connection with other aspects of human health and disease.  

This section provides an in-depth look at AARS, elucidating its essential functions and its emerging role beyond traditional protein synthesis.

Definition of AARS: What is AARS (Alanyl-tRNA Synthetase)? [5., 6.]

AARS belongs to the family of enzymes known as aminoacyl-tRNA synthetases. Its primary function is to attach the amino acid alanine to its corresponding transfer RNA (tRNA) during protein synthesis.  

AARS ensures that alanine is correctly positioned and bound to the tRNA, preventing errors in protein sequences that could have detrimental effects on cellular function.

This is crucial for maintaining the accuracy and efficiency of protein assembly. AARS achieves this through a two-step reaction, first activating alanine and then transferring it to tRNA.

Recent research indicates that the functions and health implications of AARS may extend far beyond that of gene transcription and protein synthesis.  

Dysfunction or mutations in AARS genes can lead to various human diseases, highlighting the enzyme's significance in cellular physiology and disease pathology.

The gene for AARS may contain alterations or mutations that cause loss of function of the enzymes and can confer increased risk of disease in affected humans.  [5.]  Testing for genetic alterations in the form of SNPs is increasingly available and can shed light on an individual’s potential for health and disease.  

What is a SNP?

A SNP, or single nucleotide polymorphism, refers to a variation at a single position in a gene along its DNA sequence.  A gene encodes a protein, so an alteration in that gene programs the production of an altered protein.  As a type of protein with great functionality in human health, alterations in genes for enzymes may confer a difference in function of that enzyme.  The function of that enzyme may be increased or decreased, depending on the altered protein produced.  

SNPs are the most common type of genetic variation in humans and can occur throughout the genome, influencing traits, susceptibility to diseases, and response to medications.

The completion of the Human Genome Project has significantly expanded opportunities for genetic testing by providing a comprehensive map of the human genome that facilitates the identification of genetic variations associated with various health conditions, including identifying SNPs that may cause alterations in protein structure and function.  

Genetic testing for SNPs enables the identification of alterations in genes, shedding light on their implications in health and disease susceptibility.

Functions of Alanyl-tRNA Synthetase (AARS)

AARS belongs to the family of enzymes known as aminoacyl-tRNA synthetases. Its primary function is to attach the amino acid alanine to its corresponding transfer RNA (tRNA) during protein synthesis.  

AARS ensures that alanine is correctly positioned and bound to the tRNA, preventing errors in protein sequences that could have detrimental effects on cellular function.

This is crucial for maintaining the accuracy and efficiency of protein assembly. AARS achieves this through a two-step reaction, first activating alanine and then transferring it to tRNA.

Additionally, AARS enzymes proofread tRNA aminoacylation and correct errors in protein synthesis. 

Recent research has uncovered roles for AARS beyond its traditional function in protein synthesis. AARS has been implicated in various cellular processes, including immune responses and signaling pathways. Its involvement in these pathways suggests a broader physiological significance, potentially influencing disease mechanisms and cellular homeostasis.  [1.]

Neurodegenerative Disorders

The dysregulation of AARS activity is being studied in the context of neurodegenerative disorders, suggesting its potential as a biomarker for these diseases.  Emerging evidence suggests a role for AARS in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth disease (CMT).  AARS has also been implicated in synaptic function and neuronal survival, further underscoring its significance in neurological health and disease.  [7.]

Metabolic Disorders

AARS dysregulation has also been implicated in metabolic disorders including obesity, diabetes, and metabolic syndrome. Altered AARS expression or activity has been observed in metabolic tissues such as skeletal muscle, suggesting a role in metabolic homeostasis and insulin sensitivity.  [3.]

Immunity and Autoimmune Conditions

AARS has also been linked to autoimmune diseases, where aberrant immune responses target the body's own tissues. Dysregulation of AARS may contribute to immune cell dysfunction and the perpetuation of autoimmune responses, highlighting its potential as a biomarker for these conditions.  [4.]

Cancer

AARS alterations have been reported in various cancers, with both increased and decreased expression observed depending on the cancer type. AARS dysregulation has been linked to tumor progression, metastasis, and drug resistance, highlighting its potential as a prognostic biomarker and therapeutic target in oncology.  [2.]

Lab Testing for AARS

Genetic testing for single nucleotide polymorphisms (SNPs) typically involves obtaining a sample of DNA which can be extracted from blood, saliva, or cheek swabs. 

The sample may be taken in a lab, in the case of a blood sample.  Alternatively, a saliva or cheek swab sample may be taken from the comfort of home. 

Test Preparation

Prior to undergoing genetic testing, it's important to consult with a healthcare provider or genetic counselor to understand the purpose, potential outcomes, and implications of the test. This consultation may involve discussing medical history, family history, and any specific concerns or questions. 

Additionally, individuals may be advised to refrain from eating, drinking, or chewing gum for a short period before providing a sample to ensure the accuracy of the test results. Following sample collection, the DNA is processed in a laboratory where it undergoes analysis to identify specific genetic variations or SNPs. 

Once the testing is complete, individuals will typically receive their results along with interpretation and recommendations from a healthcare professional. 

It's crucial to approach genetic testing with proper understanding and consideration of its implications for one's health and well-being.

Patient-Centric Approaches

A patient-centered approach to SNP genetic testing emphasizes individualized medicine, tailoring healthcare decisions and interventions based on an individual's unique genetic makeup.

When that is combined with the individual’s health status and health history, preferences, and values, a truly individualized plan for care is possible. 

By integrating SNP testing into clinical practice, healthcare providers can offer personalized risk assessment, disease prevention strategies, and treatment plans that optimize patient outcomes and well-being. 

Genetic testing empowers a deeper understanding of genetic factors contributing to disease susceptibility, drug response variability, and overall health, empowering patients to actively participate in their care decisions. 

Furthermore, individualized medicine recognizes the importance of considering socioeconomic, cultural, and environmental factors alongside genetic information to deliver holistic and culturally sensitive care that aligns with patients' goals and preferences. 

Through collaborative decision-making and shared decision-making processes, patients and providers can make informed choices about SNP testing, treatment options, and lifestyle modifications, promoting patient autonomy, engagement, and satisfaction in their healthcare journey.

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.  

What's 
AARS
?
If Your Levels Are High
Symptoms of High Levels
If Your Levels are Low
Symptoms of Low Levels

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register here.

Register Here
See References

[1.] Khan D, Fox PL. Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection. Biochem Soc Trans. 2023 Dec 20;51(6):2127-2141. doi: 10.1042/BST20230527. PMID: 38108455; PMCID: PMC10754286. 

[2.] Khan K, Gogonea V, Fox PL. Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis. Transl Oncol. 2022 May;19:101392. doi: 10.1016/j.tranon.2022.101392. Epub 2022 Mar 9. PMID: 35278792; PMCID: PMC8914993.

[3.] López-Soldado I, Torres AG, Ventura R, Martínez-Ruiz I, Díaz-Ramos A, Planet E, Cooper D, Pazderska A, Wanic K, O'Hanlon D, O'Gorman DJ, Carbonell T, de Pouplana LR, Nolan JJ, Zorzano A, Hernández-Alvarez MI. Decreased expression of mitochondrial aminoacyl-tRNA synthetases causes downregulation of OXPHOS subunits in type 2 diabetic muscle. Redox Biol. 2023 May;61:102630. doi: 10.1016/j.redox.2023.102630. Epub 2023 Feb 8. PMID: 36796135; PMCID: PMC9958393.

[4.] Nie A, Sun B, Fu Z, Yu D. Roles of aminoacyl-tRNA synthetases in immune regulation and immune diseases. Cell Death & Disease. 2019;10(12). doi:https://doi.org/10.1038/s41419-019-2145-5

[5.] Simons C, Griffin LB, Helman G, Golas G, Pizzino A, Bloom M, Murphy JL, Crawford J, Evans SH, Topper S, Whitehead MT, Schreiber JM, Chapman KA, Tifft C, Lu KB, Gamper H, Shigematsu M, Taft RJ, Antonellis A, Hou YM, Vanderver A. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Am J Hum Genet. 2015 Apr 2;96(4):675-81. doi: 10.1016/j.ajhg.2015.02.012. Epub 2015 Mar 26. PMID: 25817015; PMCID: PMC4385183.

[6.] Turvey AK, Horvath GA, Cavalcanti ARO. Aminoacyl-tRNA synthetases in human health and disease. Front Physiol. 2022 Oct 18;13:1029218. doi: 10.3389/fphys.2022.1029218. PMID: 36330207; PMCID: PMC9623071. 

[7.] Wang S, Sun S. Translation dysregulation in neurodegenerative diseases: a focus on ALS. Mol Neurodegener. 2023 Aug 25;18(1):58. doi: 10.1186/s13024-023-00642-3. PMID: 37626421; PMCID: PMC10464328. 

Test for

AARS

No items found.
Order, track, and receive results from 30+ labs in one place.